- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medanta performs Rare Paediatric Kidney Transplant on a 12 year old boy
Gurgaon: Kidney transplantation is considered an optimal therapy for all children with end stage renal disease with there is better longevity, quality of life and cost-effectiveness in comparison to long-term maintenance dialysis. Due to a severe shortage of suitable cadaveric donors, most paediatric patients receive a kidney from their living relatives. “If an appropriate living related donor is not available, a child may have to wait for a considerable period of time for a cadaveric donor. In such circumstances, blood group ABO incompatibility was regarded as a major obstacle in screening potential living donors”, said Dr Vijay Kher, Chairman, Nephrology, Medanta - The Medicity.
A 12-year-old boy presented to Medanta with kidney failure, was started on haemodialysis. The options of renal transplantation were discussed. The blood group of the patient was B+, and no family member had the compatible blood group, despite an extensive search for 6 months. The patient’s mother had blood group AB+. Even though the mother had a different blood group, the child received renal transplant with mother as the donor, with a designed desensitization and immunosuppressive protocol. This is the first time in India that a child has got a kidney transplant across the blood group barrier. “The child underwent a kidney transplant in Medanta, and is currently completely normal, and leading a normal school life” said Dr Sidharth Sethi, Consultant, Paediatric Nephrology, Medanta - The Medicity.
This is to emphasize to the general public and doctors that ABO incompatibility does not always mean loss of hope for children with end stage renal disease.
A 12-year-old boy presented to Medanta with kidney failure, was started on haemodialysis. The options of renal transplantation were discussed. The blood group of the patient was B+, and no family member had the compatible blood group, despite an extensive search for 6 months. The patient’s mother had blood group AB+. Even though the mother had a different blood group, the child received renal transplant with mother as the donor, with a designed desensitization and immunosuppressive protocol. This is the first time in India that a child has got a kidney transplant across the blood group barrier. “The child underwent a kidney transplant in Medanta, and is currently completely normal, and leading a normal school life” said Dr Sidharth Sethi, Consultant, Paediatric Nephrology, Medanta - The Medicity.
This is to emphasize to the general public and doctors that ABO incompatibility does not always mean loss of hope for children with end stage renal disease.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story